Fresenius Kabi Recalls Tranexamic Acid Injection Due to Particulate Matter
Fresenius Kabi USA is recalling 121,456 vials of Tranexamic Acid Injection USP due to the presence of particulate matter consistent with glass vial delamination.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the presence of glass particulate matter in an injectable medication poses a significant risk of injury, meeting the criteria for a Severe rating.
Plain-English summary
Fresenius Kabi USA, LLC is recalling 121,456 vials of Tranexamic Acid Injection USP, 1000mg/10mL, 10mL vial. The product is prescription-only and was distributed nationwide in the United States. The vials were packaged under two labels: one for APP Pharmaceuticals, LLC (NDC 63323-563-10) and one for Nexus Pharmaceuticals Inc (NDC 14789-500-10).
The recall was initiated because of the presence of particulate matter consistent with the delamination of the glass vial container. This defect involves the shedding of glass particles from the container into the medication.
Healthcare providers and patients should stop using the affected vials and contact their healthcare provider or the recalling firm for further instructions. The affected lots include specific expiration dates ranging from 2013 to 2015, as detailed in the recall notice.
The recalled product
- Product
- Tranexamic Acid Injection USP, 1000mg/10mL, 10mL vial, Rx only. Mfd by: Fresenius Kabi USA, LLC Packaged under two labels: 1) Mfd for: APP Pharmaceuticals, LLC; Schaumburg, IL 60173, NDC 63323-563-10, and 2) Mfd in USA; for Nexus Pharmaceuticals Inc; Vernon Hills, IL 60061. N
- Manufacturer
- Fresenius Kabi USA, LLC
- Category
- Drug — Injectable Medication
- Affected units
- 121,456
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (12)
- National Drug Code (NDC): 63323-563-10
- Lot Numbers and (Expiration Dates): 011713 (01/2015)
- 012213 (01/2015)
- 032913 (03/2015)
- 041613 (04/2015)
- 042513 (04/2015)
- 042613 (04/2015)
- 052213 (05/2015)
- 092612 (09/2014)
- 111512 (11/2014) NDC: 14789-500-10
- 122911 (12/2013)
- 123011 (12/2013)
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Fresenius Kabi USA, LLC
See all →- SevereFresenius Kabi Recalls Tyenne Injection Due to Glass Particles
FDA (Drugs) · 2026-09-02
- CriticalFresenius Kabi Recalls Morphine Syringes Due to Labeling Error
FDA (Drugs) · 2026-08-26
- HighXylocaine Injection Recall Due to Hair Contamination
FDA (Drugs) · 2026-07-29
- ModerateGlycopyrrolate Injection Recall Due to Hair Contamination
FDA (Drugs) · 2026-07-29
- ModerateFDA Recalls Xylocaine Injections Due to Hair Contamination
FDA (Drugs) · 2026-07-29
Same hazard · particulate matter
See all →- SevereACTHAR Gel Recalled for Presence of Glass and Stopper Particulate Matter
FDA (Drugs) · 2026-09-02
- SevereB. Braun Recalls Lactated Ringer's Injection Due to Particulate Matter
FDA (Drugs) · 2026-09-02
- CriticalAmerican Regent Recalls Papaverine Hydrochloride Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereAmerican Regent Recalls Nitroglycerin Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereAmerican Regent Recalls Cyanocobalamin Injections Due to Particulate Matter
FDA (Drugs) · 2026-08-26